1. Home
  2. DARE vs ARAY Comparison

DARE vs ARAY Comparison

Compare DARE & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$1.34

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.23

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DARE
ARAY
Founded
2015
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
39.3M
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
DARE
ARAY
Price
$1.34
$0.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$10.00
$3.50
AVG Volume (30 Days)
188.8K
1.2M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
$2,807,885.00
N/A
Revenue This Year
$2,115.12
N/A
Revenue Next Year
$122.62
$4.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$0.23
52 Week High
$3.78
$2.10

Technical Indicators

Market Signals
Indicator
DARE
ARAY
Relative Strength Index (RSI) 26.82 34.69
Support Level N/A N/A
Resistance Level $1.84 $0.29
Average True Range (ATR) 0.13 0.02
MACD -0.07 0.00
Stochastic Oscillator 16.33 8.09

Price Performance

Historical Comparison
DARE
ARAY

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: